# Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

> **NCT02040155** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 16 (actual)

## Conditions studied

- Cancer of the Cervix, Cancer of the Endometrium

## Interventions

- **DEVICE:** Novel nano-scintillator fiber-optic dosimeter (nanoFOD)

## Key facts

- **NCT ID:** NCT02040155
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040155, "Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02040155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*